Selected research
Market Structure
Global Placental Exosomes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Placental Exosomes market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Placental Exosomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Placental Exosomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Placental Exosomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Placental Exosomes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Placental Exosomes include Shenzhen Shifangjie Technology Co., Ltd., Guidon Pharmaceutics, Enze Kangtai, Beike Biotechnology, ZenBio, RoosterBio, Paracrine Therapeutics, Kimera Labs and Japan Bio Products Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Placental Exosomes output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Placental Exosomes by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Placental Exosomes market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Placental Exosomes and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Placental Exosomes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Placental Exosomes market size, projected growth trends, production technologies, key applications, and end-use industries.
Placental Exosomes Segment by Company
Shenzhen Shifangjie Technology Co., Ltd.
Guidon Pharmaceutics
Enze Kangtai
Beike Biotechnology
ZenBio
RoosterBio
Paracrine Therapeutics
Kimera Labs
Japan Bio Products Co., Ltd.
ExoQure
EXO Biologics
Creative Biolabs
BioIVT
BioCat
Aegle Therapeutics
Advancexo
Placental Exosomes Segment by Type
Placental MSC-Exosomes
Endothelial-derived Exosomes
Trophoblast-derived Exosomes
Placental Exosomes Segment by Application
Disease Diagnosis
Disease Treatment
Others
Placental Exosomes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Placental Exosomes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Placental Exosomes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Placental Exosomes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Placental Exosomes market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Placental Exosomes industry.
Chapter 3: Detailed analysis of Placental Exosomes market competition landscape. Including Placental Exosomes manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Placental Exosomes by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Placental Exosomes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Placental MSC-Exosomes
- Endothelial-derived Exosomes
- Trophoblast-derived Exosomes
Applications
- Disease Diagnosis
- Disease Treatment
- Others
Companies covered
- Shenzhen Shifangjie Technology Co., Ltd.
- Guidon Pharmaceutics
- Enze Kangtai
- Beike Biotechnology
- ZenBio
- RoosterBio
- Paracrine Therapeutics
- Kimera Labs
- Japan Bio Products Co., Ltd.
- ExoQure
- EXO Biologics
- Creative Biolabs
- BioIVT
- BioCat
- Aegle Therapeutics
- Advancexo
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Placental Exosomes Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Placental Exosomes Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Placental Exosomes Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Placental Exosomes Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Placental Exosomes Market Dynamics
- 2.1 Placental Exosomes Industry Trends
- 2.2 Placental Exosomes Industry Drivers
- 2.3 Placental Exosomes Industry Opportunities and Challenges
- 2.4 Placental Exosomes Industry Restraints
3 Placental Exosomes Market by Manufacturers
- 3.1 Global Placental Exosomes Production Value by Manufacturers (2021-2026)
- 3.2 Global Placental Exosomes Production by Manufacturers (2021-2026)
- 3.3 Global Placental Exosomes Average Price by Manufacturers (2021-2026)
- 3.4 Global Placental Exosomes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Placental Exosomes Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Placental Exosomes Manufacturers, Product Type & Application
- 3.7 Global Placental Exosomes Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Placental Exosomes Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Placental Exosomes Players Market Share by Production Value in 2025
- 3.8.3 2025 Placental Exosomes Tier 1, Tier 2, and Tier 3
4 Placental Exosomes Market by Type
- 4.1 Placental Exosomes Type Introduction
- 4.1.1 Placental MSC-Exosomes
- 4.1.2 Endothelial-derived Exosomes
- 4.1.3 Trophoblast-derived Exosomes
- 4.2 Global Placental Exosomes Production by Type
- 4.2.1 Global Placental Exosomes Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Placental Exosomes Production by Type (2021-2032)
- 4.2.3 Global Placental Exosomes Production Market Share by Type (2021-2032)
- 4.3 Global Placental Exosomes Production Value by Type
- 4.3.1 Global Placental Exosomes Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Placental Exosomes Production Value by Type (2021-2032)
- 4.3.3 Global Placental Exosomes Production Value Market Share by Type (2021-2032)
5 Placental Exosomes Market by Application
- 5.1 Placental Exosomes Application Introduction
- 5.1.1 Disease Diagnosis
- 5.1.2 Disease Treatment
- 5.1.3 Others
- 5.2 Global Placental Exosomes Production by Application
- 5.2.1 Global Placental Exosomes Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Placental Exosomes Production by Application (2021-2032)
- 5.2.3 Global Placental Exosomes Production Market Share by Application (2021-2032)
- 5.3 Global Placental Exosomes Production Value by Application
- 5.3.1 Global Placental Exosomes Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Placental Exosomes Production Value by Application (2021-2032)
- 5.3.3 Global Placental Exosomes Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Shenzhen Shifangjie Technology Co., Ltd.
- 6.1.1 Shenzhen Shifangjie Technology Co., Ltd. Company Information
- 6.1.2 Shenzhen Shifangjie Technology Co., Ltd. Business Overview
- 6.1.3 Shenzhen Shifangjie Technology Co., Ltd. Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.1.4 Shenzhen Shifangjie Technology Co., Ltd. Placental Exosomes Product Portfolio
- 6.1.5 Shenzhen Shifangjie Technology Co., Ltd. Recent Developments
- 6.2 Guidon Pharmaceutics
- 6.2.1 Guidon Pharmaceutics Company Information
- 6.2.2 Guidon Pharmaceutics Business Overview
- 6.2.3 Guidon Pharmaceutics Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.2.4 Guidon Pharmaceutics Placental Exosomes Product Portfolio
- 6.2.5 Guidon Pharmaceutics Recent Developments
- 6.3 Enze Kangtai
- 6.3.1 Enze Kangtai Company Information
- 6.3.2 Enze Kangtai Business Overview
- 6.3.3 Enze Kangtai Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.3.4 Enze Kangtai Placental Exosomes Product Portfolio
- 6.3.5 Enze Kangtai Recent Developments
- 6.4 Beike Biotechnology
- 6.4.1 Beike Biotechnology Company Information
- 6.4.2 Beike Biotechnology Business Overview
- 6.4.3 Beike Biotechnology Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.4.4 Beike Biotechnology Placental Exosomes Product Portfolio
- 6.4.5 Beike Biotechnology Recent Developments
- 6.5 ZenBio
- 6.5.1 ZenBio Company Information
- 6.5.2 ZenBio Business Overview
- 6.5.3 ZenBio Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.5.4 ZenBio Placental Exosomes Product Portfolio
- 6.5.5 ZenBio Recent Developments
- 6.6 RoosterBio
- 6.6.1 RoosterBio Company Information
- 6.6.2 RoosterBio Business Overview
- 6.6.3 RoosterBio Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.6.4 RoosterBio Placental Exosomes Product Portfolio
- 6.6.5 RoosterBio Recent Developments
- 6.7 Paracrine Therapeutics
- 6.7.1 Paracrine Therapeutics Company Information
- 6.7.2 Paracrine Therapeutics Business Overview
- 6.7.3 Paracrine Therapeutics Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.7.4 Paracrine Therapeutics Placental Exosomes Product Portfolio
- 6.7.5 Paracrine Therapeutics Recent Developments
- 6.8 Kimera Labs
- 6.8.1 Kimera Labs Company Information
- 6.8.2 Kimera Labs Business Overview
- 6.8.3 Kimera Labs Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.8.4 Kimera Labs Placental Exosomes Product Portfolio
- 6.8.5 Kimera Labs Recent Developments
- 6.9 Japan Bio Products Co., Ltd.
- 6.9.1 Japan Bio Products Co., Ltd. Company Information
- 6.9.2 Japan Bio Products Co., Ltd. Business Overview
- 6.9.3 Japan Bio Products Co., Ltd. Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.9.4 Japan Bio Products Co., Ltd. Placental Exosomes Product Portfolio
- 6.9.5 Japan Bio Products Co., Ltd. Recent Developments
- 6.10 ExoQure
- 6.10.1 ExoQure Company Information
- 6.10.2 ExoQure Business Overview
- 6.10.3 ExoQure Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.10.4 ExoQure Placental Exosomes Product Portfolio
- 6.10.5 ExoQure Recent Developments
- 6.11 EXO Biologics
- 6.11.1 EXO Biologics Company Information
- 6.11.2 EXO Biologics Business Overview
- 6.11.3 EXO Biologics Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.11.4 EXO Biologics Placental Exosomes Product Portfolio
- 6.11.5 EXO Biologics Recent Developments
- 6.12 Creative Biolabs
- 6.12.1 Creative Biolabs Company Information
- 6.12.2 Creative Biolabs Business Overview
- 6.12.3 Creative Biolabs Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.12.4 Creative Biolabs Placental Exosomes Product Portfolio
- 6.12.5 Creative Biolabs Recent Developments
- 6.13 BioIVT
- 6.13.1 BioIVT Company Information
- 6.13.2 BioIVT Business Overview
- 6.13.3 BioIVT Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.13.4 BioIVT Placental Exosomes Product Portfolio
- 6.13.5 BioIVT Recent Developments
- 6.14 BioCat
- 6.14.1 BioCat Company Information
- 6.14.2 BioCat Business Overview
- 6.14.3 BioCat Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.14.4 BioCat Placental Exosomes Product Portfolio
- 6.14.5 BioCat Recent Developments
- 6.15 Aegle Therapeutics
- 6.15.1 Aegle Therapeutics Company Information
- 6.15.2 Aegle Therapeutics Business Overview
- 6.15.3 Aegle Therapeutics Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.15.4 Aegle Therapeutics Placental Exosomes Product Portfolio
- 6.15.5 Aegle Therapeutics Recent Developments
- 6.16 Advancexo
- 6.16.1 Advancexo Company Information
- 6.16.2 Advancexo Business Overview
- 6.16.3 Advancexo Placental Exosomes Production, Value and Gross Margin (2021-2026)
- 6.16.4 Advancexo Placental Exosomes Product Portfolio
- 6.16.5 Advancexo Recent Developments
7 Global Placental Exosomes Production by Region
- 7.1 Global Placental Exosomes Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Placental Exosomes Production by Region (2021-2032)
- 7.2.1 Global Placental Exosomes Production by Region (2021-2026)
- 7.2.2 Global Placental Exosomes Production Forecast by Region (2027-2032)
- 7.3 Global Placental Exosomes Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Placental Exosomes Production Value by Region (2021-2032)
- 7.4.1 Global Placental Exosomes Production Value by Region (2021-2026)
- 7.4.2 Global Placental Exosomes Production Value by Region (2027-2032)
- 7.5 Global Placental Exosomes Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Placental Exosomes Production Value (2021-2032)
- 7.6.2 Europe Placental Exosomes Production Value (2021-2032)
- 7.6.3 Asia-Pacific Placental Exosomes Production Value (2021-2032)
- 7.6.4 South America Placental Exosomes Production Value (2021-2032)
- 7.6.5 Middle East & Africa Placental Exosomes Production Value (2021-2032)
8 Global Placental Exosomes Consumption by Region
- 8.1 Global Placental Exosomes Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Placental Exosomes Consumption by Region (2021-2032)
- 8.2.1 Global Placental Exosomes Consumption by Region (2021-2026)
- 8.2.2 Global Placental Exosomes Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Placental Exosomes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Placental Exosomes Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Placental Exosomes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Placental Exosomes Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Placental Exosomes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Placental Exosomes Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Placental Exosomes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Placental Exosomes Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Placental Exosomes Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Placental Exosomes Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Placental Exosomes Value Chain Analysis
- 9.1.1 Placental Exosomes Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Placental Exosomes Production Mode & Process
- 9.2 Placental Exosomes Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Placental Exosomes Distributors
- 9.2.3 Placental Exosomes Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst